Pathogenesis, evaluation and pathogenetic therapy of diabetic polyneuropathy
The increase in the number and life expectancy of patients with diabetes mellitus (DM) worldwide determines the high prevalence of late complications of diabetes, including diabetic polyneuropathy (DPN), the most common type of polyneuropathy. Oxidative stress is considered the main reason for the c...
Main Authors: | I. A. Strokov, V. V. Oganov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2021-06-01
|
Series: | Неврология, нейропсихиатрия, психосоматика |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1584 |
Similar Items
-
α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy
by: I. A. Strokov, et al.
Published: (2016-12-01) -
DIABETIC POLYNEUROPATHY: CURRENT APPROACHES TO DIAGNOSIS AND PATHOGENETIC THERAPY
by: O. S. Levin
Published: (2014-07-01) -
DIABETIC POLYNEUROPATHY: CURRENT APPROACHES TO DIAGNOSIS AND PATHOGENETIC THERAPY
by: O. S. Levin
Published: (2014-07-01) -
Diabetic polyneuropathy: diagnosis, prevention, and treatment
by: V. A. Golovacheva, et al.
Published: (2020-08-01) -
DIABETIC POLYNEUROPATHY: PATHOGENESIS, CLINICAL PRESETATION AND NEW APPROACHES TO PERSONALIZED TREATMENT
by: M. M. Tanashyan, et al.
Published: (2017-11-01)